CIPO

Manual of Patent Office Practice (MOPOP)

Manual of Patent Office Practice (MOPOP)  1-0

Chapter 1 Introduction to Patents and the Patent Office  1-0

1.01 Purpose of the Manual of Patent Office Practice - October 2019  1-0

1.02 Patents - October 2019  1-0

1.03 CIPO and the Patent Office – October 2019  1-2

1.04 Where to get more information - October 2019  1-2

Chapter 2 Communicating with the Patent Office  2-3

2.01 Introduction to communicating with the Patent Office – October 2019  2-3

2.02 Part 1 – Written communications  2-3

2.02.01 General requirements for submission of written communications – September 2020  2-3

2.02.02 General formatting requirements – October 2019  2-4

2.02.02a Exception for communications relating to more than one application or patent  2-4

2.02.02b Exception identifying the patent application number  2-5

2.02.03 Who can communicate with the Patent Office – October 2019  2-5

2.02.04 Updating addresses – October 2019  2-5

2.02.05 Physical delivery of written communications – October 2019  2-5

2.02.05a Regular mail or in person  2-6

2.02.05b Designated establishments – regional offices of ISED  2-6

2.02.05c Designated establishment – Registered MailTM and XpresspostTM services of Canada Post 2-7

2.02.06 Submission of documents, information and fees by electronic means – October 2019  2-7

2.02.06a Online  2-8

2.02.06b Facsimile  2-8

2.02.06c Canada as Receiving Office under the PCT: PCT-SAFE  2-9

2.02.07 Submission of documents, information or fees on electronic media – September 2020  2-9

2.02.07a Acceptable electronic formats – September 2020  2-9

2.02.08 Electronic form of sequence listings – September 2020  2-10

2.02.08a Canada as Receiving Office under the PCT: Electronic filing of sequence listings- October 2019  2-11

2.02.09 Written communications from the Commissioner of Patents or the Patent Office – October 2019  2-12

2.02.09a Practice for returned communications – October 2019  2-12

2.02.09b Practice for allegations of missing communications from the Patent Office or the Commissioner of Patents – September 2020  2-12

2.02.09b(i) Practice for Erroneous Communications from the Patent Office or the Commissioner of Patents – September 2020  2-12

2.02.09c Practice for allegations of missing communications from an external client to the Patent Office or the Commissioner of Patents – September 2020  2-13

2.02.09d Exception – written communications sent before removal or refusal from Register of Agents – October 2019  2-13

2.03 Part 2 - Time  2-14

2.03.01 Date of receipt accorded to documents, information or fees submitted to the Patent Office – October 2019  2-14

2.03.01a Date of receipt – physical delivery to Patent Office  2-14

2.03.01b Date of receipt – physical delivery to designated establishments  2-14

2.03.01c Date of receipt – submission by electronic means  2-15

2.03.02 Time limits – October 2019  2-15

2.03.02a Calculation of time limits  2-15

2.03.03 Extensions of time – October 2019  2-16

2.03.03a Time period extended for prescribed and designated days – October 2019  2-16

2.03.03b Prescribed days – October 2019  2-16

2.03.03c Unexpected closures of the office – October 2019  2-17

2.03.03d Designated days – force majeure – October 2019  2-18

2.03.03e Requests for extensions of time – subsection 3(1) of the Patent Rules – September 2020  2-18

2.03.03e(i) Extension of Time for Examiner Requisitions – September 2020  2-19

2.03.03f Non-application of subsection 3(1) of the Patent Rules – September 2020  2-20

2.03.03g Extension of time to ‘top-up’ small entity fees – subsection 3(3) of the Patent Rules – September 2020  2-21

2.03.04 Time Limits for PCT national phase applications before national phase entry – October 2019  2-22

Chapter 3 Filing a Patent Application  3-23

3.01 Introduction – Types of patent applications – October 2019  3-23

3.02 Filing a regular Canadian patent application – October 2019  3-24

3.02.01 Requirements to obtain a filing date for a regular Canadian patent application  3-24

3.02.02 Failure to provide all of the information and/or documents to secure a filing date  3-24

3.02.03 Description provided in a language other than English or French  3-25

3.02.04 Reference to a previously filed application in place of a description  3-25

3.02.04a Reference statement  3-26

3.02.04b Copy of the previously filed application  3-26

3.02.04c Translation of the previously filed application if not in English or French  3-27

3.02.05 Addition to specification or addition of drawing  3-27

3.02.05a Time period for addition  3-28

3.02.05b Effect on filing date  3-28

3.02.06 Application fee  3-29

3.02.07 Numbering of applications  3-29

3.02.08 Filing certificate  3-30

3.02.09 Withdrawal of an application  3-30

3.03 PCT national phase applications – October 2019  3-30

3.04 Divisional applications – October 2019  3-30

3.04.01 Meaning of "original application"  3-31

3.04.02 Filing requirements for divisional applications  3-31

3.04.02a Original patent application number submitted after presentation date  3-32

3.04.03 Specification and drawings submitted on the presentation date  3-32

3.04.04 Application fee for divisional application  3-32

3.04.05 Maintenance fees for divisional application  3-33

3.04.06 Consequence of not meeting the requirements of section 89 of the Patent Rules on the presentation date  3-33

3.04.07 Deadline for filing a divisional application  3-34

3.04.08 Actions deemed taken  3-34

3.04.09 Notices in respect of original application  3-35

3.04.10 Public inspection of divisional application  3-35

Chapter 4 Compliance Requirements  4-35

4.01 Introduction - Compliant Patent Applications – September 2020  4-35

4.01.01 Compliant PCT National Phase Applications – October 2019  4-36

4.02 Notice of non-compliance – September 2020  4-36

4.02.01 Notice of non-compliance - response to notice – October 2019  4-37

4.03 Petition – September 2020  4-37

4.04 Inventor information and establishing entitlement – September 2020  4-37

4.05 Drawings – September 2020  4-38

4.06 Sequence listings – September 2020  4-38

4.07 Translation of a description or previously filed application – October 2019  4-39

4.08 Notice requiring a translation of the description – subsection 15(4) of the Patent Rules – September 2020  4-39

4.09 General formatting requirements for parts of application – October 2019  4-39

Chapter 5 Representation  5-40

5.01 Introduction – October 2019  5-40

5.02 Qualifying examination for Canadian patent agents – September 2020  5-40

5.02.01 Register of patent agents – October 2019  5-41

5.02.02 Entry on Register of patent agents – September 2020  5-41

5.02.03 Maintaining name on Register of patent agents – September 2020  5-41

5.02.04 Removal from Register of patent agents – September 2020  5-42

5.02.05 Reinstatement on the Register of patent agents following removal – September 2020  5-43

5.02.06 Refusal to recognize patent agent – October 2019  5-43

5.02.07 Updates to Register of patent agents – name and address – October 2019  5-44

5.02.07a Change in name of patent agent – September 2020  5-44

5.02.07b Change of address of patent agent – September 2020  5-45

5.03 Succession of patent agent – September 2020  5-45

5.04 Common Representative – October 2019  5-46

5.04.01 Appointment of common representative – filing date or PCT national phase entry date – October 2019  5-46

5.04.02 Appointment of common representative by notice – September 2020  5-46

5.04.03 Common representative by default – applications – September 2020  5-46

5.04.04 Common representative by default – patents – October 2019  5-52

5.04.05 Common representative by default in case of transfers (applications and patents) – September 2020  5-52

5.05 Patent Agents – October 2019  5-55

5.05.01 Requirement to appoint a patent agent – October 2019  5-56

5.05.02 Commissioner’s Notice – Requirement to appoint a patent agent – October 2019  5-56

5.05.03 Appointment of patent agents – October 2019  5-56

5.05.03a Appointment of patent agent in the petition or in the request for PCT national phase entry – October 2019  5-56

5.05.03b Appointment of patent agent by notice – September 2020  5-57

5.05.03c Consent of the patent agent to the appointment – September 2020  5-57

5.05.04 Default appointment of patent agent – patents – September 2020  5-57

5.05.05 Default appointment of patent agent – transfers – October 2019  5-57

5.05.06 Revocation of appointment of patent agent – October 2019  5-58

5.06 Associate patent agents – October 2019  5-58

5.06.01 Commissioner’s Notice – requirement to appoint an associate patent agent in Canada – October 2019  5-58

5.06.02 Appointment of the associate patent agent – October 2019  5-58

5.06.02a Appointment of associate patent agent in the petition or in the request for PCT national phase entry – September 2020  5-59

5.06.02b Appointment of associate patent agent by notice – September 2020  5-59

5.06.03 Default appointment of associate patent agent – patents – September 2020  5-59

5.06.04 Revocation of appointment of associate patent agent – October 2019  5-59

5.07 Representation Requirements – what actions can be taken by whom – October 2019  5-60

5.07.01 Representation during prosecution of the patent application – September 2020  5-60

5.07.01a Representation by others – September 2020  5-61

5.07.02 List of actions and persons authorized to represent – patent applications – October 2019  5-61

5.07.02a Filing an application for a patent, paying the application fee for a patent or submission of the request to enter the PCT national phase and the payment of the associated fees – September 2020  5-61

5.07.02b Payment of annual maintenance fees – applications – October 2019